LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Travere Therapeutics (NASDAQ: TVTX)

Follow NASDAQ:TVTX Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ TVTX Travere Therapeutics
Cline Christopher R. / officer: CHIEF FINANCIAL OFFICER
04/11/2024
Sell
$6.74
54
$364
70,849
NASDAQ TVTX Travere Therapeutics
Dube Eric M / director, officer: CHIEF EXECUTIVE OFFICER
02/01/2024
Sell
$8.53
9,106
$78K
360,616
NASDAQ TVTX Travere Therapeutics
Dube Eric M / director, officer: CHIEF EXECUTIVE OFFICER
01/31/2024
Buy
$8.93
360,000
$3.215M
360,000
NASDAQ TVTX Travere Therapeutics
Dube Eric M / director, officer: CHIEF EXECUTIVE OFFICER
02/01/2024
Sell
$8.86
10,016
$89K
350,600
NASDAQ TVTX Travere Therapeutics
ROTE WILLIAM E. / officer: SENIOR VICE PRESIDENT, R&D
02/01/2024
Sell
$8.53
2,174
$19K
83,310
NASDAQ TVTX Travere Therapeutics
ROTE WILLIAM E. / officer: SENIOR VICE PRESIDENT, R&D
02/01/2024
Sell
$8.86
2,590
$23K
80,720
NASDAQ TVTX Travere Therapeutics
ROTE WILLIAM E. / officer: SENIOR VICE PRESIDENT, R&D
01/31/2024
Buy
$8.93
65,000
$580K
65,000
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
02/01/2024
Sell
$8.53
2,820
$24K
52,017
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
01/31/2024
Buy
$8.93
25,000
$223K
25,000
NASDAQ TVTX Travere Therapeutics
REED ELIZABETH E / officer: SVP, GC & CORPORATE SECRETARY
02/01/2024
Sell
$8.53
2,174
$19K
78,860
NASDAQ TVTX Travere Therapeutics
REED ELIZABETH E / officer: SVP, GC & CORPORATE SECRETARY
02/01/2024
Sell
$8.86
2,590
$23K
76,270
NASDAQ TVTX Travere Therapeutics
REED ELIZABETH E / officer: SVP, GC & CORPORATE SECRETARY
01/31/2024
Buy
$8.93
65,000
$580K
65,000
NASDAQ TVTX Travere Therapeutics
Heerma Peter / officer: CHIEF COMMERCIAL OFFICER
02/01/2024
Sell
$8.53
4,195
$36K
99,503
NASDAQ TVTX Travere Therapeutics
Heerma Peter / officer: CHIEF COMMERCIAL OFFICER
01/31/2024
Buy
$8.93
65,000
$580K
65,000
NASDAQ TVTX Travere Therapeutics
Inrig Jula / officer: CHIEF MEDICAL OFFICER
01/31/2024
Buy
$8.93
91,000
$813K
91,000
NASDAQ TVTX Travere Therapeutics
Inrig Jula / officer: CHIEF MEDICAL OFFICER
02/01/2024
Sell
$8.53
2,174
$19K
58,074
NASDAQ TVTX Travere Therapeutics
Cline Christopher R. / officer: CHIEF FINANCIAL OFFICER
02/01/2024
Sell
$8.53
3,818
$33K
70,903
NASDAQ TVTX Travere Therapeutics
Cline Christopher R. / officer: CHIEF FINANCIAL OFFICER
01/31/2024
Buy
$8.93
65,000
$580K
65,000
NASDAQ TVTX Travere Therapeutics
REED ELIZABETH E / officer: SVP, GC & CORPORATE SECRETARY
01/23/2024
Sell
$8.96
2,062
$18K
56,034
NASDAQ TVTX Travere Therapeutics
Dube Eric M / director, officer: CHIEF EXECUTIVE OFFICER
01/23/2024
Sell
$8.96
7,873
$71K
234,722
NASDAQ TVTX Travere Therapeutics
Cline Christopher R. / officer: CHIEF FINANCIAL OFFICER
01/23/2024
Sell
$9.07
853
$8K
49,721
NASDAQ TVTX Travere Therapeutics
ROTE WILLIAM E. / officer: SENIOR VICE PRESIDENT, R&D
01/23/2024
Sell
$8.96
2,062
$18K
60,484
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
01/23/2024
Sell
$9.07
910
$8K
41,337
NASDAQ TVTX Travere Therapeutics
Heerma Peter / officer: CHIEF COMMERCIAL OFFICER
01/23/2024
Sell
$9.07
1,559
$14K
78,698
NASDAQ TVTX Travere Therapeutics
Inrig Jula / officer: Chief Medical Officer
01/03/2024
Sell
$9.48
2,069
$20K
35,688
NASDAQ TVTX Travere Therapeutics
Inrig Jula / officer: Chief Medical Officer
01/04/2024
Sell
$9.17
440
$4K
35,248
NASDAQ TVTX Travere Therapeutics
Heerma Peter / officer: Chief Commercial Officer
10/03/2023
Sell
$8.25
3,091
$26K
80,257
NASDAQ TVTX Travere Therapeutics
Cline Christopher R. / officer: Chief Financial Officer
09/05/2023
Sell
$14.71
457
$7K
50,574
NASDAQ TVTX Travere Therapeutics
ROTE WILLIAM E. / officer: Senior Vice President, R&D
09/05/2023
Sell
$14.71
1,815
$27K
61,173
NASDAQ TVTX Travere Therapeutics
REED ELIZABETH E / officer: SVP, GC & Corporate Secretary
09/05/2023
Sell
$14.71
1,815
$27K
58,096
NASDAQ TVTX Travere Therapeutics
Dube Eric M / director, officer: Chief Executive Officer
09/05/2023
Sell
$14.71
4,455
$66K
242,595
NASDAQ TVTX Travere Therapeutics
Baynes Roy D. / director
05/17/2023
Buy
$17.11
13,500
$231K
13,500
NASDAQ TVTX Travere Therapeutics
Poole Sandra / director
05/17/2023
Buy
$17.11
13,500
$231K
13,500
NASDAQ TVTX Travere Therapeutics
COUGHLIN TIMOTHY / director
05/17/2023
Buy
$17.11
13,500
$231K
13,500
NASDAQ TVTX Travere Therapeutics
Williams Brinkley Ruth / director
05/17/2023
Buy
$17.11
13,500
$231K
13,500
NASDAQ TVTX Travere Therapeutics
Meckler Jeffrey A / director
05/17/2023
Buy
$17.11
13,500
$231K
13,500
NASDAQ TVTX Travere Therapeutics
Orwin John A / director
05/17/2023
Buy
$17.11
13,500
$231K
13,500
NASDAQ TVTX Travere Therapeutics
LYONS GARY A / director
05/17/2023
Buy
$17.11
13,500
$231K
13,500
NASDAQ TVTX Travere Therapeutics
Bruhn Suzanne Louise / director
05/17/2023
Buy
$17.11
13,500
$231K
13,500
NASDAQ TVTX Travere Therapeutics
Squarer Ron / director
05/17/2023
Buy
$17.11
13,500
$231K
13,500
NASDAQ TVTX Travere Therapeutics
Cline Christopher R. / officer: Chief Financial Officer
05/10/2023
Sell
$16.59
455
$8K
51,031
NASDAQ TVTX Travere Therapeutics
REED ELIZABETH E / officer: SVP, GC & Corporate Secretary
05/10/2023
Sell
$16.59
825
$14K
56,611
NASDAQ TVTX Travere Therapeutics
ROTE WILLIAM E. / officer: Senior Vice President, R&D
05/10/2023
Sell
$16.59
825
$14K
59,211
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, Chief Accounting Officer
05/10/2023
Sell
$16.59
436
$7K
42,369
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, Chief Accounting Officer
05/11/2023
Sell
$16.12
122
$2K
42,247
NASDAQ TVTX Travere Therapeutics
Cline Christopher R. / officer: Chief Financial Officer
04/11/2023
Sell
$21.49
47
$1K
51,486
NASDAQ TVTX Travere Therapeutics
REED ELIZABETH E / officer: SVP, GC & Corporate Secretary
02/01/2023
Sell
$22.25
2,590
$58K
57,436
NASDAQ TVTX Travere Therapeutics
REED ELIZABETH E / officer: SVP, GC & Corporate Secretary
01/31/2023
Buy
$22.40
54,500
$1.221M
54,500
NASDAQ TVTX Travere Therapeutics
ROTE WILLIAM E. / officer: Senior Vice President, R&D
02/01/2023
Sell
$22.25
2,590
$58K
60,036
NASDAQ TVTX Travere Therapeutics
ROTE WILLIAM E. / officer: Senior Vice President, R&D
01/31/2023
Buy
$22.40
54,500
$1.221M
54,500
NASDAQ TVTX Travere Therapeutics
Heerma Peter / officer: Chief Commercial Officer
02/01/2023
Sell
$21.75
1,779
$39K
82,069
NASDAQ TVTX Travere Therapeutics
Heerma Peter / officer: Chief Commercial Officer
01/31/2023
Buy
$22.40
54,500
$1.221M
54,500
NASDAQ TVTX Travere Therapeutics
Cline Christopher R. / officer: Chief Financial Officer
01/31/2023
Buy
$22.40
54,500
$1.221M
54,500
NASDAQ TVTX Travere Therapeutics
Cline Christopher R. / officer: Chief Financial Officer
02/01/2023
Sell
$21.75
1,588
$35K
51,533
NASDAQ TVTX Travere Therapeutics
Inrig Jula / officer: Chief Medical Officer
01/31/2023
Buy
$22.40
54,500
$1.221M
54,500
NASDAQ TVTX Travere Therapeutics
Dube Eric M / director, officer: Chief Executive Officer
01/31/2023
Buy
$22.40
260,000
$5.824M
260,000
NASDAQ TVTX Travere Therapeutics
Dube Eric M / director, officer: Chief Executive Officer
02/01/2023
Sell
$22.25
8,196
$182K
237,150
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, Chief Accounting Officer
02/01/2023
Sell
$21.75
1,671
$36K
43,165
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, Chief Accounting Officer
02/02/2023
Sell
$22.42
360
$8K
42,805
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, Chief Accounting Officer
01/31/2023
Buy
$22.40
20,000
$448K
20,000
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, Chief Accounting Officer
01/24/2023
Sell
$21.90
905
$20K
35,028
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, Chief Accounting Officer
01/25/2023
Sell
$21.63
192
$4K
34,836
NASDAQ TVTX Travere Therapeutics
ROTE WILLIAM E. / officer: Senior Vice President, R&D
01/24/2023
Sell
$21.50
2,062
$44K
42,376
NASDAQ TVTX Travere Therapeutics
REED ELIZABETH E / officer: SVP, GC & Corporate Secretary
01/24/2023
Sell
$21.50
2,062
$44K
39,776
NASDAQ TVTX Travere Therapeutics
Dube Eric M / officer: Chief Executive Officer
01/24/2023
Sell
$21.50
6,442
$139K
147,846
NASDAQ TVTX Travere Therapeutics
Cline Christopher R. / officer: Chief Financial Officer
01/24/2023
Sell
$21.90
852
$19K
32,871
NASDAQ TVTX Travere Therapeutics
Heerma Peter / officer: Chief Commercial Officer
01/24/2023
Sell
$21.90
1,550
$34K
63,598

COPYRIGHT ©2023 HEALTH STOCKS HUB

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous